InsidersTradesSigma
Track the Apotea AB (publ) share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Apotea AB (publ) has recorded 21 insider filings. Market capitalisation: €7.8bn. The latest transaction was disclosed on 28 July 2026 (Purchase). Among the most active insiders: Pär Svärdson. All data is openly available.
21
Insider Decl.
n/a
Thresholds
€4m
20 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Apotea AB (publ) Buy (bullish), based on 2 analysts. Average price target: SEK 92.50.
37Σ signal
Fundamental score
Ranked 14,879 of 29,063 companies
51.4
score / 100
Value42
Quality61
FCF yld1.5%
Earn yld2.8%
EV/EBITDA18.1x
ROE28%
Gross mgn27%
Net mgn3.2%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 July 2026
Declarations21 total
5,000 shares@ SEK 72.9970.0049% mcap100.0% of flowAktieISIN SE0023313762FI:csv-fcef01a8d9a9be0fd645
1,000 shares@ SEK 79.500.0010% mcap33.3% of flowAktieISIN SE0023313762FI:csv-0a0b6f9048879243cb1d
2,000 shares@ SEK 79.500.0020% mcap66.7% of flowAktieISIN SE0023313762FI:csv-674e0a4e5f8b1014e3cd
21,459 shares@ SEK 11.650.0003% mcap50.0% of flowAktieISIN SE0029279249FI:csv-08f4a137c8b5bdb4d42b
21,459 shares@ SEK 11.650.0003% mcap100.0% of flowAktieISIN SE0029279249FI:A003Z702-1
85,836 shares@ SEK 11.650.0011% mcap2.6% of flowAktieISIN SE0029279249FI:csv-fd4cd4a2c4c8a598bd5c
85,836 shares@ SEK 11.650.0012% mcap2.7% of flowAktieISIN SE0029279249FI:A003Z513-1
8,583 shares@ SEK 11.650.0001% mcap50.0% of flowAktieISIN SE0029279249FI:csv-d7b0e6646790d6b180b7
858 shares@ SEK 11.650.0000% mcap100.0% of flowAktieISIN SE0029279249FI:csv-f265e9c62c48480d746a
858 shares@ €1.07350.0000% mcap100.0% of flowAktieISIN SE0029279249FI:A003Z376-1
8,583 shares@ €1.07350.0001% mcap100.0% of flowAktieISIN SE0029279249FI:A003Z424-1
8,583 shares@ SEK 11.650.0001% mcap100.0% of flowAktieISIN SE0029279249FI:csv-cad083bde43e70f54fbf
8,583 shares@ €1.07540.0001% mcap100.0% of flowAktieISIN SE0029279249FI:A003Z331-1
35,907 shares@ €1.03560.0005% mcap100.0% of flowAktieISIN SE0023441506FI:A003X109-1
475,000 shares@ €5.93450.036% mcap85.6% of flowAktieISIN SE0023313762FI:A003V639-1
3,000 shares@ €5.88230.0002% mcap100.0% of flowAktieISIN SE0023313762FI:A003V632-1
81,000 shares@ €5.85950.0060% mcap14.4% of flowAktieISIN SE0023313762FI:A003V617-1
170 shares@ €5.66980.0000% mcap100.0% of flowAktieISIN SE0023313762FI:A003V616-1
36 shares@ €5.93730.0000% mcap100.0% of flowAktieISIN SE0023313762FI:A003V625-1
1,672 shares@ €1.02380.0000% mcap100.0% of flowAktieISIN SE0023313762FI:A003U741-1
40,000 shares@ €10.35290.0053% mcap100.0% of flowAktieISIN SE0023313762FI:A003R305-1
21 of 21 declarations
Acerca de Apotea AB (publ)
Apotea AB (publ) es una empresa sueca centrada en la venta en línea de productos farmacéuticos y de salud. Cotiza en la Bolsa de Estocolmo (XSTO).